John Denman

John Denman is an accomplished executive with extensive experience in the pharmaceutical industry. Currently serving as an Executive at Rosemont Pharmaceuticals since July 2023, Denman previously held influential leadership roles, including President & CEO at Avet Pharmaceuticals from April 2018 to May 2022 and CEO of the Sterile Division at Renaissance Lakewood, LLC from March 2016 to December 2017. Additionally, Denman was the General Manager for the US at Renaissance Pharma, Inc. from June 2012 to March 2016 and served as Sr. Vice President of Commercial Operations at Teva Pharmaceuticals from December 2010 to May 2012. Denman holds a Bachelor of Science in Pharmacy from Rutgers College of Pharmacy and a Juris Doctor from Widener University Schools of Law.